14159 capital gp llc - through partnership investment history in Biocryst pharmaceuticals inc

Filed on 2009-06-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-09-030389.txt Sec File: edgar/data/1317493/0001144204-09-030389-index.htm

2009-06-01 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc sold 1314 shares at $3.885 remaining shares owned 120828

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of 14159, l.p.


Filed on 2009-06-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-09-030389.txt Sec File: edgar/data/1317493/0001144204-09-030389-index.htm

2009-06-01 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc sold 3392 shares at $3.8641 remaining shares owned 122142

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of 14159, l.p.


Filed on 2009-06-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-09-030389.txt Sec File: edgar/data/1317493/0001144204-09-030389-index.htm

2009-05-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc sold 3249 shares at $4.1228 remaining shares owned 125534

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of 14159, l.p.


Filed on 2009-06-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-09-030389.txt Sec File: edgar/data/1317493/0001144204-09-030389-index.htm

2009-05-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc sold 631 shares at $4.3013 remaining shares owned 128783

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of 14159, l.p.


Filed on 2009-06-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-09-030389.txt Sec File: edgar/data/1317493/0001144204-09-030389-index.htm

2009-05-28 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc sold 4677 shares at $4.5041 remaining shares owned 129414

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of 14159, l.p.


Filed on 2009-06-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-09-030389.txt Sec File: edgar/data/1317493/0001144204-09-030389-index.htm

2009-05-28 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc sold 2597 shares at $4.4535 remaining shares owned 134091

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of 14159, l.p.


Filed on 2008-11-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-066456.txt Sec File: edgar/data/1317493/0001144204-08-066456-index.htm

2008-11-24 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc bought 201 shares at $0.9778 remaining shares owned 136688

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of baker brothers life sciences, l.p.


Filed on 2008-11-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-066456.txt Sec File: edgar/data/1317493/0001144204-08-066456-index.htm

2008-11-21 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc bought 848 shares at $0.9141 remaining shares owned 136487

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of baker brothers life sciences, l.p.


Filed on 2008-11-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-066456.txt Sec File: edgar/data/1317493/0001144204-08-066456-index.htm

2008-11-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc bought 8278 shares at $1 remaining shares owned 135639

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f4 stephen r. biggar, an employee of baker bros. advisors llc, is a director of the company. baker bros. advisors, llc is the management company of baker brothers life sciences, l.p.


Filed on 2007-08-08 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 3

Accession 0001144204-07-041197.txt Sec File: edgar/data/1317493/0001144204-07-041197-index.htm

2007-08-06 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Biocryst Pharmaceuticals Inc remaining shares owned 127361

Common Stock Biocryst Pharmaceuticals Inc Bcrx

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.
f5 stephen r. biggar, an employee of baker bros. advisors, llc, is a director of the issuer. baker bros. advisors, llc is the management company of 14159, l.p.